Rajan Sharma
Stock Analyst at Goldman Sachs
(0)
# 4852
Out of 5,368 analysts
7
Total ratings
0.00%
Success rate
-21.09%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
DBVT DBV Technologies | Reinstates: Sell | 8 | 9.08 | -20.15% | 1 | May 29, 2025 | |
AZN AstraZeneca | Initiates Coverage On: Buy | 97 | 74.39 | 30.39% | 1 | May 30, 2024 | |
GSK GSK | Initiates Coverage On: Neutral | 47 | 40.85 | 15.06% | 1 | May 30, 2024 | |
MOR MorphoSys | Maintains: Neutral | 10 5 | n/a | n/a | 2 | Nov 22, 2023 | |
IMCR Immunocore Hldgs | Reiterates: Overweight | 79 | 34.66 | 127.93% | 2 | Jun 20, 2023 |